Dashboard
Manage Tickers

INMB Inmune Bio, Inc.

Nasdaq inmunebio.com


$ 1.83 $ 0.10 (5.78 %)    

Friday, 31-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 1.83
$ 1.75
$ 1.74 x 521
$ 1.87 x 2
$ 1.75 - $ 1.93
$ 1.71 - $ 11.64
506,716
na
48.65M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-05-2021 03-31-2021 10-Q
20 03-04-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-11-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-29-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inmune-bio-q3-adj-eps-024-beats-033-estimate
INmune Bio Q3 Adj. EPS $(0.24) Beats $(0.3...
10/30/2025 20:14:06

INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.33) by...

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

inmune-bio-submits-manuscript-detailing-results-of-phase-2-mindful-trial-to-nature-portfolio-journal-npj-dementia
INmune Bio Submits Manuscript Detailing Re...
09/29/2025 12:02:58

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces the submission of a manu...

inmune-bio-completes-first-full-scale-pilot-commercial-manufacturing-run-of-cordstrom-umbilical-cord-tissue-derived-mesenchymal-stromal-cell-therapy-for-treatment-of-rdeb
INmune Bio Completes First Full-Scale Pilo...
09/15/2025 12:10:16

INmune Bio Inc. (NASDAQ:INMB) ("INmune" or "the Company"), a clinical-stage inflammation and immunology company...

correction-inmune-bio-q2-adj-eps-034-beats-039-estimate
CORRECTION: INmune Bio Q2 Adj. EPS $(0.34)...
08/07/2025 22:38:11

INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by...

inmune-bio-inc-appoints-david-moss-as-president-and-ceo-cory-ellspermann-appointed-interim-cfo-kelly-ganjei-appointed-chairman-of-the-board
Inmune Bio Inc Appoints David Moss As Pres...
08/07/2025 21:37:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 21:08:09

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
Traders Circulate Business Insider Article...
08/06/2025 14:34:09

https://www.businessinsider.com/short-squeeze-stock-market-meme-stocks-retail-investors-25-8

inmune-bios-inkmune-meets-primary-and-secondary-endpoints-in-phase-iii-trial-for-metastatic-prostate-cancer
INmune Bio's INKmune Meets Primary And Sec...
08/04/2025 12:20:46

 INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage immunology and inflammation company, is pleased to rep...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/04/2025 12:08:38

Core News & Articles
INmune Bio To Share New Alzheimer's Trial ...
07/29/2025 11:04:36

INmune Bio Inc. (NASDAQ:INMB) announced today that a video detailing the additional findings from the Phase 2 MINDFuL trial eva...

why-celcuity-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Celcuity Shares Are Trading Higher By ...
07/28/2025 09:38:47

inmune-bio-rebounds-sharply-during-after-hours-trading-whats-driving-the-surge
INmune Bio Rebounds Sharply During After H...
07/28/2025 09:33:45

Following the announcement of TNF inhibitor, INmune Bio Inc. stock surged by 24.72% in after-hours trading on Friday.

inmune-bio-to-present-new-phase-2-data-on-alzheimers-drug-xpro-at-aaic-on-july-29
INmune Bio to Present New Phase 2 Data on ...
07/24/2025 11:08:35

INmune Bio Inc. (NASDAQ:INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel...

pharma-bro-martin-shkreli-says-good-chance-inmune-bio-stock-will-slip-90-on-monday
'Pharma Bro' Martin Shkreli Says 'Good Cha...
07/04/2025 13:20:13

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days...

pharma-bro-martin-shkreli-says-good-chance-inmune-bio-stock-will-slip-90-on-monday
'Pharma Bro' Martin Shkreli Says 'Good Cha...
07/04/2025 13:20:07

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days...

maxim-group-maintains-buy-on-inmune-bio-lowers-price-target-to-8
Maxim Group Maintains Buy on INmune Bio, L...
07/02/2025 16:00:16

Maxim Group analyst Jason McCarthy maintains INmune Bio (NASDAQ:INMB) with a Buy and lowers the price target from $30 to $8.

this-textron-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Textron Analyst Is No Longer Bullish;...
07/01/2025 16:59:42

btig-downgrades-inmune-bio-to-neutral
BTIG Downgrades INmune Bio to Neutral
07/01/2025 14:00:24

BTIG analyst Thomas Shrader downgrades INmune Bio (NASDAQ:INMB) from Buy to Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION